Intellia Therapeutics, Inc. · 4 days ago
Strategic Accounts Director - West
Cambridge, MA
Full-time
Hybrid
Director/Executive
$225K/yr - $275K/yr
10+ years expIntellia Therapeutics, Inc. is dedicated to developing curative genome editing treatments for severe diseases. They are seeking an experienced Strategic Accounts Director to lead a team focused on activating treatment sites and ensuring the delivery of their CRISPR therapy to patients.
BiotechnologyGeneticsHealth CareMedicalTherapeutics
Responsibilities
Build, lead, and mentor a high-performing team of Strategic Account Liaisons focused on activating treatment sites, building operational care pathways, and infusion capabilities to ensure pull-through and administration of Intellia therapies
Establish clear goals, performance metrics, and development plans to support team growth and success
Foster a culture of collaboration, accountability, and continuous improvement
Define and drive the strategy for treatment site enablement, ensuring alignment with sales, medical, patient services, marketing, commercial operations, and market access
Develop a roadmap for treatment center activation, operational excellence, and long-term scalability
Serve as a thought leader and internal advocate for treatment center needs
Partner with Sales, Medical Affairs, Market Access, Marketing, Commercial Operations, and Patient Services to ensure seamless treatment center activation and support
Represent the treatment center function in leadership forums and strategic planning discussions
Partner with commercial leadership to provide updates on performance and site activation
Oversee the development and implementation of standardized processes for treatment center profiling, qualification, and training
Monitor treatment center performance and drive continuous improvement in key metrics such as turnaround time, compliance, and capacity utilization
Ensure adherence to regulatory and quality standards across all treatment center activities
Build and maintain strong relationships with treatment center leadership, including C-suite, P&T committee members, pharmacy leadership, and revenue cycle managers
Serve as a senior point of contact for escalations, strategic partnerships, and long-term planning with key institutions
Represent the company at industry forums, conferences, and working groups related to treatment site readiness and enablement
Build and lead a new team focused on site and treatment center strategy and operations
Optimize team structure, roles, and responsibilities to support current and future business needs
Lead recruitment, onboarding, and development of team members
Foster a collaborative, inclusive, and high-performance culture that encourages innovation and accountability
Provide coaching, mentorship, and performance management to ensure team success and professional growth
Qualification
Required
Bachelor's degree in life sciences, business, healthcare administration, or related field; advanced degree (MBA, MPH, PharmD) a plus
10+ years of experience in biotech/pharma, health systems, and treatment site activation for high-cost, buy and bill, HCP administered therapies, with at least 3–5 years in a leadership role
Proven track record of successfully partnering cross functionally to build and lead the establishment of a new function and organizational capabilities
Management and oversight of functional budget and resourcing
Proven track record of introducing novel, impactful approaches that challenge convention and accelerate the delivery of innovative therapies to patients
Ability to engage with C-Level stakeholders
Project management and cross functional coordination experience
Ability to navigate complex health systems
Experience leading site activation in cell and gene therapy
History of engaging multiple internal and external stakeholders and building strong partnerships with them
Demonstrates outstanding verbal, written, and interpersonal skills with the ability to influence others and build strong relationships across a diverse stakeholder landscape
Deep understanding of the stakeholder ecosystem within treatment sites including health systems, IDNs, and hospitals
Proven ability to lead teams, manage complex projects, and influence across a matrixed organization
Experience launching and scaling capabilities for complex, high-cost, buy-and-bill therapies
Results-driven self-starter with a strong sense of accountability, performance orientation, and the ability to collaborate effectively across functional teams
Organized and logical with a high degree of flexibility and adaptability
Comfortable navigating ambiguity and shifting priorities, with a high degree of flexibility to pivot as needed
Preferred
Ideally, the candidate will have experience with one-time therapies
Benefits
Performance-based annual cash bonus
New hire equity grant
Eligibility to be considered for annual equity awards
Company
Intellia Therapeutics, Inc.
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$1.54BKey Investors
OrbiMed
2022-11-30Post Ipo Equity· $300M
2021-06-30Post Ipo Equity· $690M
2020-11-30Post Ipo Equity· $201M
Leadership Team
John Leonard
President and Chief Executive Officer, Member Board of Directors
Edward Dulac
Chief Financial Officer
Recent News
Labiotech UG
2026-01-22
Clinical Trials Arena
2026-01-16
Company data provided by crunchbase